| Antiviral activities of lactoferrin BWA Van der Strate, L Beljaars, G Molema, MC Harmsen, DKF Meijer Antiviral research 52 (3), 225-239, 2001 | 646 | 2001 |
| Albumin Modified With Mannose 6–Phosphate: A Potential Carrier for Selective Delivery of Antifibrotic Drugs to Rat and Human Hepatic Stellate Cells L Beljaars, G Molema, B Weert, H Bonnema, P Olinga, GM Groothuis, ... Hepatology 29 (5), 1486-1493, 1999 | 222 | 1999 |
| Drug targeting to the diseased liver K Poelstra, J Prakash, L Beljaars Journal of controlled release 161 (2), 188-197, 2012 | 196 | 2012 |
| Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor L Beljaars, G Molema, D Schuppan, A Geerts, PJ De Bleser, B Weert, ... Journal of Biological Chemistry 275 (17), 12743-12751, 2000 | 196 | 2000 |
| Reduction of advanced liver fibrosis by short‐term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats M Moreno, T Gonzalo, RJ Kok, P Sancho‐Bru, M Van Beuge, J Swart, ... Hepatology 51 (3), 942-952, 2010 | 172 | 2010 |
| Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides B Berkhout, JLB van Wamel, L Beljaars, DKF Meijer, S Visser, R Floris Antiviral research 55 (2), 341-355, 2002 | 164 | 2002 |
| The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue L Beljaars, B Weert, A Geerts, DKF Meijer, K Poelstra Biochemical pharmacology 66 (7), 1307-1317, 2003 | 144 | 2003 |
| Novel engineered targeted interferon‐gamma blocks hepatic fibrogenesis in mice R Bansal, J Prakash, E Post, L Beljaars, D Schuppan, K Poelstra Hepatology 54 (2), 586-596, 2011 | 124 | 2011 |
| Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis L Beljaars, DK Meijer, K Poelstra Front Biosci 7 (1), e214-e222, 2002 | 120 | 2002 |
| HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects S Klein, MM Van Beuge, M Granzow, L Beljaars, R Schierwagen, S Kilic, ... Journal of hepatology 57 (6), 1220-1227, 2012 | 110 | 2012 |
| Characteristics of the hepatic stellate cell‐selective carrier mannose 6‐phosphate modified albumin (M6P28‐HSA) L Beljaars, P Olinga, G Molema, P De Bleser, A Geerts, GMM Groothuis, ... Liver 21 (5), 320-328, 2001 | 108 | 2001 |
| Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells T Gonzalo, L Beljaars, M van de Bovenkamp, K Temming, ... Journal of Pharmacology and Experimental Therapeutics 321 (3), 856-865, 2007 | 106 | 2007 |
| Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo L Beljaars, BWA van der Strate, HI Bakker, C Reker-Smit, FC Wiegmans, ... Antiviral research 63 (3), 197-208, 2004 | 106 | 2004 |
| Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans L Beljaars, M Schippers, C Reker-Smit, FO Martinez, L Helming, ... Frontiers in immunology 5, 109533, 2014 | 99 | 2014 |
| Targeted therapies in liver fibrosis: combining the best parts of platelet-derived growth factor BB and interferon gamma F Van Dijk, P Olinga, K Poelstra, L Beljaars Frontiers in medicine 2, 72, 2015 | 79 | 2015 |
| Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice MM Van Beuge, J Prakash, M Lacombe, R Gosens, E Post, C Reker-Smit, ... Journal of Pharmacology and Experimental Therapeutics 337 (3), 628-635, 2011 | 79 | 2011 |
| The elusive antifibrotic macrophage A Adhyatmika, KSS Putri, L Beljaars, BN Melgert Frontiers in medicine 2, 81, 2015 | 78 | 2015 |
| The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo R Greupink, HI Bakker, W Bouma, C Reker-Smit, DKF Meijer, L Beljaars, ... Journal of Pharmacology and Experimental Therapeutics 317 (2), 514-521, 2006 | 78 | 2006 |
| Gliotoxin non‐selectively induces apoptosis in fibrotic and normal livers WI Hagens, P Olinga, DKF Meijer, GMM Groothuis, L Beljaars, K Poelstra Liver international 26 (2), 232-239, 2006 | 78 | 2006 |
| Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis R Bansal, J Prakash, M Ruijter, L Beljaars, K Poelstra Molecular pharmaceutics 8 (5), 1899-1909, 2011 | 71 | 2011 |
